VAERS Explorer
Back to explore

Report #2832929

Received Mar 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (4)

Mobility decreasedNasopharyngitisPainPain in extremity

Symptom narrative

catching a bad cold; Aching body all over; All extremeties hurt; difficulty moving; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cold in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced cold (Verbatim: catching a bad cold), general body pain (Verbatim: Aching body all over), pain in extremity (Verbatim: All extremeties hurt) and mobility decreased (Verbatim: difficulty moving). The outcome of the cold and mobility decreased were not reported and the outcome of the general body pain and pain in extremity were resolving. It was unknown if the reporter considered the cold, general body pain, pain in extremity and mobility decreased to be related to Arexvy. It was unknown if the company considered the cold, general body pain, pain in extremity and mobility decreased to be related to Arexvy. Additional Information: GSK Receipt Date : 14-MAR-2025 This case was reported by a patient via interactive digital media. Physical symptoms were catching a bad cold. Aching body all over. All extremities hurt , difficulty moving. However once he/she started moving the soreness dissipated.